肝移植围术期镇痛的最佳管理对术后即刻及短期结局的影响:系统评价、Meta分析与专家小组建议
该系统评价与Meta分析遵循PRISMA指南、采用GRADE方法,共筛选1910篇文献,最终纳入2项随机对照试验、1项前瞻性研究和6项回顾性研究,评估肝移植围术期不同镇痛管理对结局、并发症、死亡率、疼痛评分及ICU和住院时间的影响。避免阿片类药物的方案(包括胸段硬膜外镇痛、腹横肌平面阻滞及其他非阿片类镇痛药)较对照组死亡率降低(OR=0.51;CI 0.14, 1.83;P=0.350),拔管时间和ICU住院时间缩短,术后疼痛评分降低(分别降低35%、12%和55%),但住院时间延长(增加8%)。专家小组据此提出弱推荐:对乙酰氨基酚(扑热息痛)、加巴喷丁、氯胺酮、曲马多和局部麻醉可替代阿片类药物或作为术后镇痛的辅助用药。总体证据仍较弱,需要更高质量的研究。
要点
- 肝移植围术期避免阿片类药物的镇痛方案(胸段硬膜外镇痛、腹横肌平面阻滞及其他非阿片类镇痛药)较对照组死亡率降低(OR=0.51;CI 0.14, 1.83;P=0.350)。
- 避免阿片类药物组拔管时间和ICU住院时间缩短,术后疼痛评分分别降低35%、12%和55%,但住院时间延长8%。
- 专家小组弱推荐:对乙酰氨基酚(扑热息痛)、加巴喷丁、氯胺酮、曲马多和局部麻醉可替代阿片类药物或作为术后镇痛的辅助用药(证据质量中至低,推荐强度弱)。
- 总体证据仍较弱,需要更稳健的研究。
适用人群与场景
- 接受肝移植的患者,围术期(术中及术后)需要镇痛管理。
处置流程与药物剂量
- 避免阿片类药物的方案包括胸段硬膜外镇痛、腹横肌平面阻滞及其他非阿片类镇痛药。
- 专家小组弱推荐:对乙酰氨基酚(扑热息痛)、加巴喷丁、氯胺酮、曲马多和局部麻醉可替代阿片类药物或作为术后镇痛的辅助用药(证据质量中至低,推荐强度弱)。
研究设计与关键结果
- 系统评价与Meta分析遵循PRISMA指南、采用GRADE方法,共筛选1910篇文献,最终纳入2项随机对照试验、1项前瞻性研究和6项回顾性研究。
- 避免阿片类药物组较对照组死亡率降低(OR=0.51;CI 0.14, 1.83;P=0.350)。
- 避免阿片类药物组拔管时间和ICU住院时间缩短,术后疼痛评分分别降低35%、12%和55%,但住院时间延长8%。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析及专家小组建议;采用GRADE方法,证据质量中至低,推荐强度弱。
- 局限:总体证据仍较弱,需要更稳健的研究。
对床旁实践的改变
- 作者认为,肝移植围术期避免阿片类药物的镇痛管理可改善短期结局(证据质量中至低,推荐强度弱)。
- 专家小组弱推荐:对乙酰氨基酚(扑热息痛)、加巴喷丁、氯胺酮、曲马多和局部麻醉可替代阿片类药物或作为术后镇痛的辅助用药。
指南或共识出处
- Clin Transplant发表的系统评价、Meta分析与专家小组建议(CRD42021243282)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Adequate pain control is essential for patients undergoing liver transplantation (LT). Multiple analgesic strategies have been implemented during the perioperative period. There is no consensus on the optimal perioperative analgesia management.
OBJECTIVES: To provide recommendations, on the optimal perioperative analgesia management for LT.
DATA SOURCES: Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central.
METHODS: A systematic review and meta-analysis following PRISMA guidelines and recommendations using GRADE. Studies describing outcomes, morbidity, mortality, pain scores, intensive care unit and hospital length of stay in patients that received different pain management techniques during and after LT were included (CRD42021243282).
RESULTS: One thousand nine hundred ten articles were screened, but only two randomized controlled trials, one prospective and six retrospective studies were included. The opioid-avoidance protocols included, thoracic epidural analgesia (TEA), Transversus Abdominis Plane (TAP) block, as well as other non-opioid analgesics, resulted in improved short-term outcomes. Mortality was reduced in this group versus control cohorts (OR = 0.51; CI 0.14, 1.83; P = 0.350), Time to extubation, and intensive care unit LOS were shorter; pain scores after surgery were lower in opioid-avoidance group (percentage decrease, 35%, 12%, and 55%, respectively). However, hospital LOS was longer (percentage increase 8%).
CONCLUSIONS: Opioid-avoidance analgesia management for LT results in improved short-term outcomes. (Quality of Evidence; Moderate to low | Grade of Recommendation; Weak). Medications such as acetaminophen(paracetamol), gabapentin, ketamine, tramadol and local anesthesia may be used instead of, or as adjuncts to opioids for postoperative analgesia. Overall evidence remains weak and more robust studies are required.
参考来源
- Sun LY, Gitman M, Malik A, et al. Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations. Clin Transplant. 2022. PMID: 35285074. doi:10.1111/ctr.14640
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。